Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciliberto

Showing results (531-540 of 839) with videos related to

Pageof 84
Sort By:
Journal of Translational Medicine|July 30, 2013
Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodiesLuigi Fattore, Emanuele Marra, Maria Elena Pisanu, et al.
Oncogene|March 4, 2016
Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growthM M Morrison, M M Williams, D B Vaught, et al.
Critical Reviews in Oncology/Hematology|December 4, 2020
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectivesDaniele Marinelli, Raffaele Giusti, Marco Mazzotta, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 16, 2019
Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growthLuigi Aurisicchio, Erika Salvatori, Lucia Lione, et al.
Human Gene Therapy|June 7, 2008
Therapeutic vaccination halts disease progression in BALB-neuT mice: the amplitude of elicited immune response is predictive of vaccine efficacyBarbara Cipriani, Arthur Fridman, Claus Bendtsen, et al.
ESMO Open|April 15, 2022
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysisM A Siciliano, G Caridà, D Ciliberto, et al.
Cancers|February 15, 2022
An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast CancerSusan Costantini, Andrea Polo, Francesca Capone, et al.
Journal of Cellular Physiology|June 18, 2015
Genetic and Functional Analysis of Polymorphisms in the Human Dopamine Receptor and Transporter Genes in Small Cell Lung CancerEmanuela Cherubini, Arianna Di Napoli, Alessia Noto, et al.
Molecular Vision|June 14, 2005
Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitorFumi Kinose, Giuseppe Roscilli, Stefania Lamartina, et al.
Journal of Translational Medicine|November 19, 2015
Alliance Against Cancer, the network of Italian cancer centers bridging research and carePaolo De Paoli, Gennaro Ciliberto, Manlio Ferrarini, et al.
Pageof 84

Showing results (531-540 of 839) with videos related to

Sort By:
Pageof 84
Journal of Translational Medicine|July 30, 2013
Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodiesLuigi Fattore, Emanuele Marra, Maria Elena Pisanu, et al.
Oncogene|March 4, 2016
Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growthM M Morrison, M M Williams, D B Vaught, et al.
Critical Reviews in Oncology/Hematology|December 4, 2020
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectivesDaniele Marinelli, Raffaele Giusti, Marco Mazzotta, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 16, 2019
Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growthLuigi Aurisicchio, Erika Salvatori, Lucia Lione, et al.
Human Gene Therapy|June 7, 2008
Therapeutic vaccination halts disease progression in BALB-neuT mice: the amplitude of elicited immune response is predictive of vaccine efficacyBarbara Cipriani, Arthur Fridman, Claus Bendtsen, et al.
ESMO Open|April 15, 2022
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysisM A Siciliano, G Caridà, D Ciliberto, et al.
Cancers|February 15, 2022
An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast CancerSusan Costantini, Andrea Polo, Francesca Capone, et al.
Journal of Cellular Physiology|June 18, 2015
Genetic and Functional Analysis of Polymorphisms in the Human Dopamine Receptor and Transporter Genes in Small Cell Lung CancerEmanuela Cherubini, Arianna Di Napoli, Alessia Noto, et al.
Molecular Vision|June 14, 2005
Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitorFumi Kinose, Giuseppe Roscilli, Stefania Lamartina, et al.
Journal of Translational Medicine|November 19, 2015
Alliance Against Cancer, the network of Italian cancer centers bridging research and carePaolo De Paoli, Gennaro Ciliberto, Manlio Ferrarini, et al.
Pageof 84